Log in

Relevant bibliographies by topics / MI prognosis / Journal articles

To see the other types of publications on this topic, follow the link: MI prognosis.

Journal articles on the topic 'MI prognosis'

Author: Grafiati

Published: 7 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'MI prognosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Asghar, Naeem, Hafiz Muhammad Faiq Ilyas, and Touseef Anwar. "PROGNOSIS OF ACUTE INFERIOR WALL MI;." Professional Medical Journal 24, no. 03 (2017): 398–402. http://dx.doi.org/10.29309/tpmj/2017.24.03.1547.

Full text

Abstract:

Introduction: Atrioventricular (AV) block is a common complication of acuteMyocardial Infarction (MI). In pre-thrombolytic era, high (second or third degree) AV blockwas seen in approximately 5-7% of patients presenting with acute MI. In setting of Inferior MI,this was even as high as 28%. Although, the advent of thrombolytic therapy has substantiallydecreased the mortality associated with acute MI, the incidence of AV block, particularly in thesetting of inferior MI, remains high. AV block in the setting of inferior MI is also associated withhigh in-hospital mortality, however, its effect on

APA, Harvard, Vancouver, ISO, and other styles

2

&NA;. "Acute MI: prognosis post GUSTO-I." Inpharma Weekly &NA;, no. 984 (1995): 16. http://dx.doi.org/10.2165/00128413-199509840-00032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Martsevich, S. Yu, O. S. Afonina, A. V. Zagrebelnyy, et al. "Comparative assessment of long-term survival of patients after primary and recurrent myocardial infarction: a data from the RIMIS registry." Cardiovascular Therapy and Prevention 23, no. 5 (2024): 4001. http://dx.doi.org/10.15829/1728-8800-2024-4001.

Full text

Abstract:

Aim. To compare the long-term prognosis of life of patients after primary and recurrent acute myocardial infarction (MI).Material and methods. The study was based on the RIMIS registry, which included all patients after transmural MI in 2017 in one of the Moscow vascular centers. The prospective part included 191 patients who survived the acute stage of MI, of which 145 suffered a primary acute MI, 46 — a recurrent acute MI. Long-term follow-up data were collected 71 (53;75) months after discharge from the hospital. The primary endpoint was any-cause death.Results. During the follow-up period,

APA, Harvard, Vancouver, ISO, and other styles

4

Putot, Alain, Frédéric Chague, Patrick Manckoundia, Yves Cottin, and Marianne Zeller. "Post-Infectious Myocardial Infarction: New Insights for Improved Screening." Journal of Clinical Medicine 8, no. 6 (2019): 827. http://dx.doi.org/10.3390/jcm8060827.

Full text

Abstract:

Acute infection is suspected of involvement in the onset of acute myocardial infarction (MI). We aimed to assess the incidence, pathogenesis and prognosis of post-infectious MI. All consecutive patients hospitalized for an acute MI in coronary care units were prospectively included. Post-infectious MI was defined by a concurrent diagnosis of acute infection at admission. Type 1 MI (acute plaque disruption) or Type 2 MI (imbalance in oxygen supply/demand) were adjudicated according to the universal definition of MI. From the 4573 patients admitted for acute MI, 466 (10%) had a concurrent acute

APA, Harvard, Vancouver, ISO, and other styles

5

Sato, Ryota, Kenji Sakamoto, Koichi Kaikita, et al. "Long-Term Prognosis of Patients with Myocardial Infarction Type 1 and Type 2 with and without Involvement of Coronary Vasospasm." Journal of Clinical Medicine 9, no. 6 (2020): 1686. http://dx.doi.org/10.3390/jcm9061686.

Full text

Abstract:

While prognoses in relation to myocardial infarction (MI) type have been elucidated in past reports, the results were not consistent, perhaps due to occurrence of Type 2 MI with CVS and its mortality. The Japanese registry of acute Myocardial Infarction diagnosed by Universal Definition (J-MINUET) is a prospective multicenter registry in Japan. In contrast to thromboembolic event-related Type 1 myocardial infarction (MI), clinical features of Type 2 MI, including coronary vasospasm (CVS), are varied due to the heterogeneous nature of its development. To elucidate the MI type-related all-cause

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "Thrombolysis improves prognosis in right ventricular MI." Inpharma Weekly &NA;, no. 952 (1994): 15. http://dx.doi.org/10.2165/00128413-199409520-00039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Martens, E. J., P. W. Hoen, M. Mittelhaeuser, P. de Jonge, and J. Denollet. "Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis." Psychological Medicine 40, no. 5 (2009): 807–14. http://dx.doi.org/10.1017/s0033291709990997.

Full text

Abstract:

BackgroundIndividual symptoms of post-myocardial infarction (MI) depression may be differentially associated with cardiac prognosis, in which somatic/affective symptoms appear to be associated with a worse cardiovascular prognosis than cognitive/affective symptoms. These findings hold important implications for treatment but need to be replicated before conclusions regarding treatment can be drawn. We therefore examined the relationship between depressive symptom dimensions following MI and both disease severity and prospective cardiac prognosis.MethodPatients (n=473) were assessed on demograp

APA, Harvard, Vancouver, ISO, and other styles

8

Zuidersma, M., J. Ormel, H. J. Conradi, and P. de Jonge. "An increase in depressive symptoms after myocardial infarction predicts new cardiac events irrespective of depressive symptoms before myocardial infarction." Psychological Medicine 42, no. 4 (2011): 683–93. http://dx.doi.org/10.1017/s0033291711001784.

Full text

Abstract:

BackgroundDepression after myocardial infarction (MI) is associated with poor cardiovascular prognosis. There is some evidence that specifically depressive episodes that develop after the acute event are associated with poor cardiovascular prognosis. The aim of the present study was to evaluate whether an increase in the number of depressive symptoms after MI is associated with new cardiac events.MethodIn 442 depressed and 325 non-depressed MI patients the Composite International Diagnostic Interview interview to assess post-MI depression was extended to evaluate the presence of the ICD-10 dep

APA, Harvard, Vancouver, ISO, and other styles

9

Chin, Wei-Chih, Pao-Hsien Chu, Lung-Sheng Wu, et al. "The Prognostic Significance of Sleep and Circadian Rhythm for Myocardial Infarction Outcomes: Case-Control Study." Journal of Medical Internet Research 27 (February 4, 2025): e63897. https://doi.org/10.2196/63897.

Full text

Abstract:

Background Myocardial infarction (MI) is a medical emergency resulting from coronary artery occlusion. Patients with acute MI often experience disturbed sleep and circadian rhythm. Most previous studies assessed the premorbid sleep and circadian rhythm of patients with MI and their correlations with cardiovascular disease. However, little is known about post-MI sleep and circadian rhythm and their impacts on prognosis. The use of actigraphy with different algorithms to evaluate sleep and circadian rhythm after acute MI has the potential for predicting outcomes and preventing future disease pro

APA, Harvard, Vancouver, ISO, and other styles

10

Zukhriddinovich, Zhalolov Bakhrom. "Integrated Management of Post-Myocardial Infarction Patients Using Genetic Analysis and Remote Control." European Multidisciplinary Journal of Modern Science 1, no. 1 (2024): 1–8. http://dx.doi.org/10.51699/emjms.v1i1.5.

Full text

Abstract:

Coronary heart disease (CHD) remains a leading cause of mortality and morbidity worldwide, particularly due to complications following myocardial infarction (MI). Despite advancements in therapeutic strategies, the prognosis for MI patients varies significantly, necessitating a comprehensive approach that integrates genetic and non-genetic factors. This study addresses the knowledge gap by evaluating the influence of genetic polymorphisms and non-genetic factors on the 12-month prognosis of MI patients. Using a cohort of 250 post-MI patients, we conducted genetic analysis on polymorphisms of t

APA, Harvard, Vancouver, ISO, and other styles

11

Isegawa, Kengo, Yoshitaka Hirooka, Masato Katsuki, Takuya Kishi, and Kenji Sunagawa. "Angiotensin II type 1 receptor expression in astrocytes is upregulated leading to increased mortality in mice with myocardial infarction-induced heart failure." American Journal of Physiology-Heart and Circulatory Physiology 307, no. 10 (2014): H1448—H1455. http://dx.doi.org/10.1152/ajpheart.00462.2014.

Full text

Abstract:

Enhanced central sympathetic outflow worsens left ventricular (LV) remodeling and prognosis in heart failure after myocardial infarction (MI). Previous studies suggested that activation of brain angiotensin II type 1 receptors (AT1R) in the brain stem leads to sympathoexcitation due to neuronal AT1R upregulation. Recent studies, however, revealed the importance of astrocytes for modulating neuronal activity, but whether changes in astrocytes influence central sympathetic outflow in heart failure is unknown. In the normal state, AT1R are only weakly expressed in astrocytes. We hypothesized that

APA, Harvard, Vancouver, ISO, and other styles

12

TORABI, A., J. CLELAND, K. GOODE, and A. RIGBY. "Prevalence and prognosis of anaemiain post MI patients." European Journal of Heart Failure Supplements 7 (June 2008): 24. http://dx.doi.org/10.1016/s1567-4215(08)60068-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Abdu, Fuad A., Abdul-Quddus Mohammed, Lu Liu, Yawei Xu, and Wenliang Che. "Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): A Review of the Current Position." Cardiology 145, no. 9 (2020): 543–52. http://dx.doi.org/10.1159/000509100.

Full text

Abstract:

Myocardial infarction with nonobstructive coronary arteries (MINOCA) remains a puzzling clinical entity that is characterized by clinical evidence of myocardial infarction (MI) with normal or near-normal coronary arteries on angiography (stenosis <50%). Major advances in understanding this condition have been made in recent years. The precise pathogenesis is poorly understood and is being studied and examined further. Guidelines indicate that MINOCA is a group of heterogeneous diseases with different mechanisms of pathology. Since there are multiple possible pathological mechanisms, it is n

APA, Harvard, Vancouver, ISO, and other styles

14

Oblavatskiy, Dmitriy V., Svetlana A. Boldueva, and Mariya V. Solovyeva. "Myocardial infarction type 2 and myocardial injury: The current state of the problem." HERALD of North-Western State Medical University named after I.I. Mechnikov 13, no. 1 (2021): 5–13. http://dx.doi.org/10.17816/mechnikov59717.

Full text

Abstract:

Today, the most difficult in terms of diagnosis and treatment today among various types of myocardial infarction (MI) is MI type 2 (MI-2). The lack of clinical guidelines for management of patients with this type of MI, as well as the literature data on prevalence, patient characteristics and prognosis contributes to the scientific relevance of the further research.

APA, Harvard, Vancouver, ISO, and other styles

15

Zhou, Jiamin, Tong Wen, Qing Li, et al. "Single-Cell Sequencing Revealed Pivotal Genes Related to Prognosis of Myocardial Infarction Patients." Computational and Mathematical Methods in Medicine 2022 (March 12, 2022): 1–15. http://dx.doi.org/10.1155/2022/6534126.

Full text

Abstract:

Objectives. Myocardial infarction (MI) is a common cardiovascular disease. Histopathology is a main molecular characteristic of MI, but often, differences between various cell subsets have been neglected. Under this premise, MI-related molecular biomarkers were screened using single-cell sequencing. Methods. This work examined immune cell abundance in normal and MI samples from GSE109048 and determined differences in the activated mast cells and activated CD4 memory T cells, resting mast cells. Weighted gene coexpression network analysis (WGCNA) demonstrated that activated CD4 memory T cells w

APA, Harvard, Vancouver, ISO, and other styles

16

Yalovenko, M.I., and O.O. Khaniukov. "Features of the myocardial infarction course in patients with a permanent atrial fibrillation." Medicni perspektivi 23, no. 2 part 1 (2018): 64–68. https://doi.org/10.26641/2307-0404.2018.2(part1).129518.

Full text

Abstract:

Atrial fibrillation (AF) is the most common cardiac arrhythmias in the population. Nowadays, AF is regarded as potentially lethal arrhythmia, considering the broad range of its negative consequences, not only due to significant deterioration in the quality of the patients’ life, but also due to related significant increase in the incidence of serious complications and death. The presence of permanent AF is associated with a twofold increase in the risk of myocardial infarction (MI) development. The purpose of the research is to study the features of the MI course, the condition of intrac

APA, Harvard, Vancouver, ISO, and other styles

17

Nordenskjöld, Anna M., Lars Lindhagen, Björn Wettermark, and Bertil Lindahl. "Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries." PLOS One 20, no. 5 (2025): e0324533. https://doi.org/10.1371/journal.pone.0324533.

Full text

Abstract:

Background Poor adherence to secondary preventive medication after myocardial infarction (MI) negatively affects long-term prognosis, but knowledge is lacking regarding the impact of poor adherence on prognosis for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA). We therefore investigated the effect of persistence to secondary preventive medication on prognosis in patients with MINOCA compared with patients with myocardial infarction with obstructive coronary arteries (MI-CAD). Methods In this nationwide observational study of 116,143 patients with MI record

APA, Harvard, Vancouver, ISO, and other styles

18

Paiva, Luis, Rui Providência, Sérgio Barra, Paulo Dinis, Ana C. Faustino, and Lino Gonçalves. "Universal Definition of Myocardial Infarction: Clinical Insights." Cardiology 131, no. 1 (2015): 13–21. http://dx.doi.org/10.1159/000371739.

Full text

Abstract:

Aims: The universal definition of myocardial infarction (MI) classifies acute ischaemia into different classes according to lesion mechanism. Our aim was to perform a detailed comparison between these different types of MI in terms of baseline characteristics, management and prognosis. Methods and Results: An observational retrospective single-centre cohort study was performed, including 1,000 consecutive patients admitted for type 1 (76.4%) or type 2 MI (23.6%). Type 2 MI patients were older, had a higher prevalence of comorbidities and worse medical status at admission. In-hospital mortality

APA, Harvard, Vancouver, ISO, and other styles

19

Fedotova, A. I., I. N. Vorozhtsova, I. V. Маksimov, et al. "THE EFFECT OF INTENSIVE GLYCEMIC CONTROL ON THE FACTORS DETERMINING PREDICTION COMPLICATIONS OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES." Bulletin of Siberian Medicine 14, no. 5 (2015): 91–99. http://dx.doi.org/10.20538/1682-0363-2015-5-91-99.

Full text

Abstract:

Objective. To determine predictors of complications of myocardial infarction (MI) in patients with type 2 diabetes (2TDM) and it’s value of intensive glycemic control during insulin infusion.Methods. The study included 112 patients with MI and 2TDM at first day of hospital admission with blood glucose level above 7.8 mmol/l. Prognosis of combined study endpoint included the death and ma-jor complications of MI for the hospital and long-term (6-month) stages. The statistical analysis was per-formed (Statistica 6.0 for Windows). The predictive value was assessed with ROC-curves analysis meth-od.

APA, Harvard, Vancouver, ISO, and other styles

20

Shishkina, E. A., O. V. Khlynova, Yu I. Lebedeva, E. N. Safarov, and N. A. Naumova. "Atrial Fibrillation and Myocardial Infarction: Clinical and Pathogenic Correlations and Impact for the Prognosis." Doctor.Ru 22, no. 8 (2023): 23–28. http://dx.doi.org/10.31550/1727-2378-2023-22-8-23-28.

Full text

Abstract:

Aim. To summarize the contemporary literature data on the clinical and pathogenic correlations between atrial fibrillation (AF) and myocardial infarction (MI). Key points. AF is one of the most common and clinically significant arrhythmias. In patients with MI, this type of arrhythmia is recorded for the first time in 6 % to 21 % of cases. The review discusses the incidence of AF in patients with various forms of coronary heart disease, mechanisms of arrhythmogenesis, and the ways to predict poor outcomes in a group of patients with AF who had a history of MI. Conclusion. The mechanisms of AF

APA, Harvard, Vancouver, ISO, and other styles

21

Gard, Anton, Bertil Lindahl, Nermin Hadziosmanovic, and Tomasz Baron. "Treatment and Prognosis of Myocardial Infarction Outside Cardiology Departments." Journal of Clinical Medicine 10, no. 1 (2020): 106. http://dx.doi.org/10.3390/jcm10010106.

Full text

Abstract:

Aim: Our aim was to investigate the characteristics, treatment and prognosis of patients with myocardial infarction (MI) treated outside a cardiology department (CD), compared with MI patients treated at a CD. Methods: A cohort of 1310 patients diagnosed with MI at eight Swedish hospitals in 2011 were included in this observational study. Patients were followed regarding all-cause mortality until 2018. Results: A total of 235 patients, exclusively treated outside CDs, were identified. These patients had more non-cardiac comorbidities, were older (mean age 83.7 vs. 73.1 years) and had less ofte

APA, Harvard, Vancouver, ISO, and other styles

22

Varma, G. "Post MI Pericardial Effusion-“Size Does Matter”." Indian Journal of Cardiovascular Disease in Women WINCARS 01, no. 04 (2016): 013–18. http://dx.doi.org/10.1055/s-0038-1656496.

Full text

Abstract:

AbstractPost myocardial infarction pericardial effusion (PE) is a relatively common, however the prognosis and management is not always straightforward in patients with moderate pericardial effusion (MPE). This article describes four case scenarios we encountered and reviews existing literature regarding etiology and management of post MI pericardial effusion.

APA, Harvard, Vancouver, ISO, and other styles

23

Galyavich, A. S., A. A. Sabirzyanova, L. V. Baleeva, and Z. M. Galeeva. "The role of growth differentiation factor-15 in assessing the prognosis of patients after uncomplicated myocardial infarction." Kardiologiia 63, no. 2 (2023): 40–45. http://dx.doi.org/10.18087/cardio.2023.2.n2152.

Full text

Abstract:

Aim To study the role of growth differentiation factor 15 (GDF-15) in the long-term prognosis for patients after uncomplicated myocardial infarction (MI).Material and methods This study included 118 MI patients aged <70 years with and without ST-segment elevation on electrocardiogram (ECG). All patients underwent an examination that included ECG, echocardiography, Holter ECG monitoring, routine laboratory tests, and tests for plasma N-terminal pro-brain natriuretic peptide (NT-proBNT) and GDF-15. GDF-15 was measured by ELISA. The dynamics of patients was evaluated by interviews at 1, 3, 6,

APA, Harvard, Vancouver, ISO, and other styles

24

Pereverzeva, K. G., S. S. Yakushin, A. S. Galus, and A. R. Shanina. "Genetic and nongenetic factors in assessing the prognosis of patients after myocardial infarction with high medical adherence." Cardiovascular Therapy and Prevention 20, no. 4 (2021): 2773. http://dx.doi.org/10.15829/1728-8800-2021-2773.

Full text

Abstract:

Aim. During one-year follow-up, to assess the effect of genetic and nongenetic factors on the risk of poor outcomes in patients after myocardial infarction (MI) with high medical adherence.Material and methods. The study included 250 patients admitted to the hospital due to MI in the period from September 1, 2018 to May 1, 2019 and with a potentially high medical adherence. Twelve months after MI, patients were assessed for adherence to therapy and the effect of genetic and nongenetic factors on the patient prognosis.Results. Within 12 months after MI, 70 (28,0%) patients had a composite endpo

APA, Harvard, Vancouver, ISO, and other styles

25

Shanbhag, Sujata M., Anders M. Greve, Thor Aspelund, et al. "Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults." European Heart Journal 40, no. 6 (2018): 529–38. http://dx.doi.org/10.1093/eurheartj/ehy713.

Full text

Abstract:

Abstract Aims Non-ischaemic cardiomyopathies (NICM) can cause heart failure and death. Cardiac magnetic resonance (CMR) detects myocardial scar/fibrosis associated with myocardial infarction (MI) and NICM with late gadolinium enhancement (LGE). The aim of this study was to determine the prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in a community-based sample of older adults. Methods and results The ICELAND-MI cohort, a substudy of the Age, Gene/Environment Susceptibility Reykjavik (AGES-Reykjavik) study, provided a well-characterized population of 900 subjects af

APA, Harvard, Vancouver, ISO, and other styles

26

Osteresch, Rico, Andreas Fach, Johannes Schmucker, et al. "Long-Term Risk Factor Control After Myocardial Infarction—A Need for Better Prevention Programmes." Journal of Clinical Medicine 8, no. 8 (2019): 1114. http://dx.doi.org/10.3390/jcm8081114.

Full text

Abstract:

Introduction: Long-term prognosis of myocardial infarction (MI) is still serious, especially in patients with MI and cardiogenic shock. To improve long-term prognosis and prevent recurrent events, sustainable cardiovascular risk factor control (RFC) after MI is crucial. Methods: The article gives an overview on health care data regarding RFC after MI and presents recent trials on modern preventive strategies that support patients to achieve risk factor targets during long-term course. Results: International registry studies, such as EUROASPIRE, observed alarming deficiencies in RFC after MI. A

APA, Harvard, Vancouver, ISO, and other styles

27

Soloveva, Mariia V., and Svetlana A. Boldueva. "Incidence of Coronary Embolism in Group of Patients with Atrial Fibrillation and Myocardial Infarction." Cardiac Arrhythmias 2, no. 3 (2022): 31–38. http://dx.doi.org/10.17816/cardar111979.

Full text

Abstract:

Embolic myocardial infarction (EMI) is more common than gets to be diagnosed. EMI is often associated with atrial fibrillation (AF). The incidence of this pathology, prognosis and treatment tactics remain unclear. AIM: To assess the incidence of EMI among patients with myocardial infarction (MI), genesis of coronary embolism (CE), initial characteristics, treatment and prognosis in group of patients with EMI. MATERIALS AND METHODS: The group of patients with EMI was selected among 1989 patients with MI admitted to the cardiology department of the North-Western State Medical Univers

APA, Harvard, Vancouver, ISO, and other styles

28

Bekke-Hansen, S., M. Trockel, M. M. Burg, and C. Barr Taylor. "Depressive symptom dimensions and cardiac prognosis following myocardial infarction: results from the ENRICHD clinical trial." Psychological Medicine 42, no. 1 (2011): 51–60. http://dx.doi.org/10.1017/s0033291711001000.

Full text

Abstract:

BackgroundDepression following myocardial infarction (MI) independently increases risk for early cardiac morbidity and mortality. Studies suggest that somatic, but not cognitive, depressive symptoms are responsible for the increased risk. However, the effects of somatic depressive symptoms at follow-up, after sufficient time has elapsed to allow for physical recovery from the initial infarction, are not known. Our aim was to examine the relationship between cognitive and somatic depressive symptom dimensions at baseline and 12 months post-MI and subsequent mortality and cardiovascular morbidit

APA, Harvard, Vancouver, ISO, and other styles

29

Zheng, Jie, Jingjing Yu, and Tao Zhou. "Clinical characteristics of breast ductal carcinoma in situ with microinvasion: a narrative review." Journal of International Medical Research 48, no. 11 (2020): 030006052096930. http://dx.doi.org/10.1177/0300060520969304.

Full text

Abstract:

Ductal carcinoma in situ (DCIS) with microinvasion (DCIS-MI) is defined as the extension of cancer cells beyond the basement membrane into adjacent tissue with no focus larger than 1 mm or a maximum diameter of less than 1 mm for multiple invasive foci. DCIS-MI constitutes approximately 1% of all breast cancer cases and 5% to 10% of cases of DCIS. The current literature is controversial concerning the clinical prognostic features and management of DCIS-MI. This narrative review described recently reported literature regarding the characteristics, diagnosis, treatment, and prognosis of DCIS-MI.

APA, Harvard, Vancouver, ISO, and other styles

30

ÜNLÜ, Ufuk, and Nagihan YILDIZ ÇELTEK. "Inflamasyon ilişkili indeksler, palyatif bakım hastalarında kötü prognozu tanımlayabilir mi?" Journal of Contemporary Medicine 12, no. 4 (2022): 565–69. http://dx.doi.org/10.16899/jcm.1098435.

Full text

Abstract:

Aim: Palliative medicine provides holistic care to increase the quality of life of patients. Predicting prognosis is critical for a personalized treatment plan. Therefore, we aimed to investigate the survival prediction properties of routine biochemistry tests, complete blood count (CBC) and neutrophil/lymphocyte ratios, in addition to biomarker-based indices (the mGPS, PI, and PNI). Materials and methods: The laboratory parameter values, prognostic factor scores, diagnoses and survival time of 139 palliative care patients in the last 5 weeks of their life were evaluated retrospectively. Resul

APA, Harvard, Vancouver, ISO, and other styles

31

Martsevich, S. Yu. "Recurrent myocardial infarction as an unsolved problem of evidence-based medicine." Cardiovascular Therapy and Prevention 23, no. 6 (2024): 4019. http://dx.doi.org/10.15829/1728-8800-2024-4019.

Full text

Abstract:

The author brings out opinion on the prognostic role of recurrent myocardial infarction (MI) at the present time. For many years, recurrent MI was considered one of the most severe complications of primary MI. Differences in the official and scientific definition of recurrent MI are examined. These differences are the reason for the ambiguous assessment of the prevalence and prognostic role of recurrent MI. Analysis of the literature data makes it possible to conclude that recurrent MI is still accompanied by significantly higher mortality rates, both in the acute phase and in the long term,

APA, Harvard, Vancouver, ISO, and other styles

32

Asghar, Dr Naeem, Dr Hafiz Muhammad Faiq Ilyas, and Dr Touseef Anwar. "PROGNOSIS OF ACUTE INFERIOR WALL MI; COMPLICATED BY ATRIOVENTRICULAR BLOCKS." PROFESSIONAL MEDICAL JOURNAL 24, no. 03 (2017): 398–402. http://dx.doi.org/10.17957/tpmj/17.3591.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

&NA;. "Early intervention with metoprolol after acute MI - long term prognosis." Inpharma Weekly &NA;, no. 808 (1991): 13. http://dx.doi.org/10.2165/00128413-199108080-00035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

&NA;. "Acute MI? - your prognosis is now better than it was." Inpharma Weekly &NA;, no. 814 (1991): 14. http://dx.doi.org/10.2165/00128413-199108140-00036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

TORABI, A., J. CLELAND, N. KHAN, et al. "795 Prevalence and prognosis of HF in post MI patients." European Journal of Heart Failure Supplements 5, no. 1 (2006): 192. http://dx.doi.org/10.1016/s1567-4215(06)80546-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

German, A. I., D. Yu Sedykh, O. N. Hryachkova, and V. V. Kashtalap. "Abdominal obesity and ten-year prognosis of patients with myocardial infarction." Complex Issues of Cardiovascular Diseases 10, no. 1 (2021): 26–39. http://dx.doi.org/10.17802/2306-1278-2021-10-1-26-39.

Full text

Abstract:

Aim. To assess the relationship of abdominal obesity with left ventricular systolic function and to predict outcomes in patients with MI within 10 years.Methods. 581 medical records of patients enrolled in the Acute coronary Syndrome Registry between 2008 and 2010 were retrospectively reviewed for the period of 10 years. The following clinical endpoints were collected: all-cause mortality, cardiovascular mortality, recurrent myocardial infarction, stroke, hospitalization due to unstable angina and decompensated heart failure. Baseline left ventricular ejection fraction (LVEF) and the presence

APA, Harvard, Vancouver, ISO, and other styles

37

Pyda, Małgorzata, Stefan Grajek, Weronika Oleśkowska-Florek, et al. "Aborted myocardial infarction in patients undergoing primary percutaneous coronary intervention." Journal of Medical Science 84, no. 1 (2015): 27–33. http://dx.doi.org/10.20883/medical.e32.

Full text

Abstract:

Introduction. The outcome of patients with ST-elevation myocardial infarction (STEMI) strongly depends on a successful reperfusion. In some patients receiving an effective treatment myocardial infarction can be aborted.Aim. The aim of the study was to estimate the incidence, clinical outcome, prognosis and inflammatory response in patients with aborted MI.Material and methods. 119 consecutive patients with STEMI treated with a primary percutaneous coronary intervention (pPCI) were enrolled in the study. Aborted MI was diagnosed when the maximal increase in cardiac enzymes (CK-MB) was up to twi

APA, Harvard, Vancouver, ISO, and other styles

38

Zhang, Yuanyuan, Chunyang Tian, Xuejian Liu, and He Zhang. "Identification of Genetic Biomarkers for Diagnosis of Myocardial Infarction Compared with Angina Patients." Cardiovascular Therapeutics 2020 (November 10, 2020): 1–12. http://dx.doi.org/10.1155/2020/8535314.

Full text

Abstract:

Background. Myocardial infarction (MI) is the most terrible appearance of cardiovascular disease. The incidence of heart failure, one of the complications of MI, has increased in the past few decades. Therefore, the identification of MI from angina patients and the determination of new diagnoses and therapies of MI are increasingly important. The present study was aimed at identifying differentially expressed genes and miRNAs as biomarkers for the clinical and prognosis factors of MI compared with angina using microarray data analysis. Methods. Differentially expressed miRNAs and genes were ma

APA, Harvard, Vancouver, ISO, and other styles

39

Özbay, Sedat, Abuzer Coskun, and Sevki Hakan Eren. "Can Platelet/Mean Platelet Volume ratio, Neutrophil/lymphocyte ratio, and Procalcitonin used for Predicting Prognosis in Acute Coronary Syndrome?" Journal of Anesthesiology and Pain Therapy 1, no. 1 (2020): 4–10. http://dx.doi.org/10.29245/2768-5365/2020/1.1103.

Full text

Abstract:

Objective: This study aimed to evaluate acute coronary syndrome (ACS), serum procalcitonin levels, Platelet/Mean Platelet Volume ratio (PMR) and Neutrophil/lymphocyte ratio (NLR) concerning post-myocardial infarction (MI) complications, mortality, and morbidity. Material and Method: The study included a total of 913 patients with ACS who presented to the emergency department with chest pain between January 2013 and December 2017. The patients were categorized as ST-elevated MI (STEMI), non-ST elevated MI (NSTEMI) and unstable angina (UA) according to the diagnosis. The demographic and laborato

APA, Harvard, Vancouver, ISO, and other styles

40

Hala, El Assili, Eddhima Zaidane, Britel Driss, et al. "Left Ventricular Aneurysm and Ventricular Septal Defect Following Myocardial Infarction: A Dangerous Cocktail." RA JOURNAL OF APPLIED RESEARCH 07, no. 06 (2021): 2409–15. https://doi.org/10.47191/rajar/v7i6.06.

Full text

Abstract:

ABSTRACT   An ischemic ventricular septal defect (VSD) is a lethal complication of myocardial infarction (MI), commonly from 24 hours to up to 5 days of presentation with AMI. Despite the improvement of surgical techniques, the mortality is still very high with poor prognosis. Left ventricular aneurysm (LVA) may also be a fatal mechanical complication of MI but rarely occurs in the posterior or inferior portion of the interventricular septum. Concomitant AMI mechanical complications in the same patient are less than infrequent with poor prognosis, particularly with late hospital arrival.

APA, Harvard, Vancouver, ISO, and other styles

41

Misiewicz, Aleksander, Krzysztof Badura, Oliwia Matuszewska-Brycht, Jan Krekora, and Jarosław Drożdż. "Iron Deficiency as a Factor of Worse Prognosis in Patients with Acute Myocardial Infarction." Biomedicines 13, no. 4 (2025): 769. https://doi.org/10.3390/biomedicines13040769.

Full text

Abstract:

Acute coronary syndromes (ACS) are a leading cause of death and impairment in the adult population. Precise identification and modification of risk factors is crucial for a favorable clinical outcome. In this review, we aim to provide a comprehensive overview of the significance of iron deficiency (ID) in patients with ACS, particularly myocardial infarction (MI). The paper evaluates the impact of ID on the prognosis of ACS patients, highlighting its potential influence on myocardial healing, regeneration and cardiovascular events during the follow-up period. The findings suggest that iron def

APA, Harvard, Vancouver, ISO, and other styles

42

Zykov, M. V., N. V. Dyachenko, and O. L. Barbarash. "Role of comorbidity in assessment of long-term prognosis after myocardial infarction." Medical alphabet 1, no. 29 (2021): 28–32. http://dx.doi.org/10.33667/2078-5631-2021-29-28-32.

Full text

Abstract:

The aim of the study. To compare different methods for assessing comorbidity in terms of its long-term predictive value after myocardial infarction (MI).Materials and methods. The analysis included 1176 patients with MI who were consecutively admitted to the hospital. The incidence of STsegment elevation MI was 60%; every second patient underwent endovascular intervention. All patients underwent an analysis of the severity of comorbidity according to the CIRS system (Cumulative lllness Rating Scale), according to the CCI (the Charlson’s comorbidity index), the CDS scale of chronic diseases (Ch

APA, Harvard, Vancouver, ISO, and other styles

43

Putot, Alain, Frédéric Chagué, Patrick Manckoundia, et al. "Post-Infectious Myocardial Infarction: Does Percutaneous Coronary Intervention Improve Outcomes? A Propensity Score-Matched Analysis." Journal of Clinical Medicine 9, no. 6 (2020): 1608. http://dx.doi.org/10.3390/jcm9061608.

Full text

Abstract:

Acute infection is a frequent trigger of myocardial infarction (MI). However, whether percutaneous coronary intervention (PCI) improves post-infectious MI prognosis is a major but unsolved issue. In this prospective multicenter study from coronary care units, we performed propensity score-matched analysis to compare outcomes in patients with and without PCI for post-infectious MI with angiography-proven significant coronary stenosis (>50%). Among 4573 consecutive MI patients, 476 patients (10%) had a concurrent diagnosis of acute infection at admission, of whom 375 underwent coronary angiog

APA, Harvard, Vancouver, ISO, and other styles

44

Sabirzyanova, A. S., A. S. Galyavich, L. V. Baleeva, and Z. V. Galeeva. "Growth differentiation factor-15 — a new indicator of unfavorable prognosis in uncomplicated myocardial infarction." Russian Journal of Cardiology 28, no. 8 (2023): 5381. http://dx.doi.org/10.15829/1560-4071-2023-5381.

Full text

Abstract:

Aim. To evaluate the role of growth differentiation factor-15 (GDF-15) in long-term prognosis in patients with uncomplicated myocardial infarction (MI).Material and methods. The study included 118 patients with uncomplicated ST-elevation and non-ST-elevation MI. In addition to the routine examination, all patients were analyzed for GDF-15, as well as the N-terminal pro-brain natriuretic peptide (NT-proBNP) by enzyme immunoassay in the first 48 hours from the onset of MI symptoms. The changes in the patients' condition were assessed by questioning after 1, 3, 6, 12 months, as well as the analys

APA, Harvard, Vancouver, ISO, and other styles

45

Petrova, M. M., A. R. Leiman, S. A. Ustyugov, N. A. Schneider, and A. V. Petrov. "Vascular cognitive impairment in patients after acute myocardial infarction." Russian Journal of Cardiology 30, no. 6S (2025): 6087. https://doi.org/10.15829/1560-4071-2025-6087.

Full text

Abstract:

Patients with acute myocardial infarction (MI) are identified by Russian and foreign experts as a risk group for moderate vascular cognitive impairment (VCI) and vascular dementia. As a result of various pathogenetic mechanisms, patients with MI develop the so-called cardiac cerebral syndrome, which makes a significant contribution to global cognitive impairment in this group of patients. The impact of MI on the risk and progression of cognitive impairment is one of the key links in improving the prognosis and quality of life in patients after MI. The aim of the review was to analyze the incid

APA, Harvard, Vancouver, ISO, and other styles

46

Samaras, Athanasios, Dimitrios V. Moysidis, Andreas S. Papazoglou, et al. "Myocardial Infarction with Obstructive, Non-Obstructive, and Mimicking Conditions: Clinical Phenotypes, Diagnostic Imaging, Management, and Prognosis." Journal of Clinical Medicine 14, no. 9 (2025): 3006. https://doi.org/10.3390/jcm14093006.

Full text

Abstract:

Background/Objectives: Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a heterogenous clinical entity that differs in pathophysiology, treatment, and prognosis from myocardial infarction with obstructive coronary artery disease (MI-CAD) and MINOCA mimickers, such as myocarditis or Takotsubo syndrome. This study aimed to compare the clinical characteristics, imaging findings, management strategies, and long-term outcomes of patients with true MINOCA, MI-CAD, and MINOCA mimickers. Methods: This retrospective cohort study included 1596 patients hospitalized with acute myo

APA, Harvard, Vancouver, ISO, and other styles

47

Moussaoui, F. "Epidemiological Profile of Myocardial Infarction with Non-Significant Stenosis of Coronary Arteries (MINOCA)." Cardiology Research and Reports 5, no. 5 (2023): 01–09. http://dx.doi.org/10.31579/2692-9759/103.

Full text

Abstract:

Background: Myocardial infarction with non-obstructive coronary arteries (MINOCA) remains a puzzling clinical entity characterized by clinical evidence of myocardial infarction (MI) with normal or near-normal coronary arteries on angiography (stenosis < 50%). This pathology is poorly understood, several studies are underway for a better understanding of this disease. The aim of our work was to review the literature and assess the epidemiology, clinical features, prognosis and etiologies of MINOCA. Methods: Descriptive, prospective study, spread over a period of 36 months from January 2018 t

APA, Harvard, Vancouver, ISO, and other styles

48

Rekhraj, Sushma, Benjamin Szwejkowski, and Allan Struthers. "Reducing Cardiovascular Risk in Patients following MI with Eplerenone." Clinical Medicine Insights: Therapeutics 2 (January 2010): CMT.S5231. http://dx.doi.org/10.4137/cmt.s5231.

Full text

Abstract:

Background In the event of an MI, the presence of LV systolic dysfunction with or without heart failure is associated with a poorer prognosis. Elevation of aldosterone levels also results in a poor prognosis after an MI. Objective This review discusses the cardiovascular benefits of blocking the aldosterone receptor using eplerenone therapy in post MI patients. Methods A literature search of Pubmed was conducted for relevant English language articles published between 1990–2010 using the search terms eplerenone, aldosterone, myocardial infarction, heart failure and endothelial dysfunction. Add

APA, Harvard, Vancouver, ISO, and other styles

49

Kinash, V. I., A. S. Vorobev, I. A. Urvantseva, L. V. Kovalenko, and V. V. Kashtalap. "Controversial issues of type 2 myocardial infarction patients management." Complex Issues of Cardiovascular Diseases 11, no. 1 (2022): 78–89. http://dx.doi.org/10.17802/2306-1278-2022-11-1-78-89.

Full text

Abstract:

Highlights. The article presents relevant literary data on the epidemiology, main causes, approaches to the diagnostics and treatment of type 2 myocardial infarction patients. The authors emphasize an unfavorable prognosis in these patients due to comorbidity that leads to development of myocardial infarction. They highlight the need to improve and unify approaches to identifying this phenomenon, as well as the necessity to conduct observational and randomized studies to evaluate approaches to the treatment of type 2 myocardial infarction patients.Abstract. The article summarizes the available

APA, Harvard, Vancouver, ISO, and other styles

50

van Beek, M. H., R. C. Oude Voshaar, G. Pop, and A. E. Speckens. "Aspects of cardiac anxiety in patients with a myocardial infarction." European Psychiatry 33, S1 (2016): S152. http://dx.doi.org/10.1016/j.eurpsy.2016.01.276.

Full text

Abstract:

IntroductionWhen the heart is in danger – as is true during a myocardial infarction (MI) – this is life-threatening and as such can provoke specific fear: so-called cardiac anxiety. Both general anxiety and depression are associated with cardiac prognosis in MI-patients. However, as most treatment studies have not shown beneficial effects on cardiac prognosis, the need to examine specific aspects of anxiety and depression post-MI has been advocated.MethodsWe examined whether cardiac anxiety can be reliably assessed with the Cardiac Anxiety Questionnaire (CAQ) in 237 hospitalized MI-patients. C

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!